InvestorsHub Logo
Followers 37
Posts 4190
Boards Moderated 0
Alias Born 10/18/2016

Re: None

Wednesday, 12/20/2017 1:12:48 PM

Wednesday, December 20, 2017 1:12:48 PM

Post# of 28505
Compensated Awareness Post View Disclaimer
PBIO Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at one of the world’s largest biopharmaceutical firms, the software upgrade makes the company’s instrument one of the few Good Manufacturing Practices-compliant, computer-controlled sample preparation systems available on the worldwide life sciences market today. “In essence, the 2320EXT offers rapid and reproducible sample preparation for the characterization and quality control of biotherapeutics, now coupled with the assurance of GMP ready software control, achieving a pivotally important requirement for the biopharmaceutical industry,” Dr. Alexander Lazarev, PBIO’s vice president of research and development, stated in the news release.

To view the full press release, visit http://nnw.fm/V6vbl

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBIO News